MSD Gulf Commited to bringing out the best in medicine
Contact UsMerck Worldwide
   
Healthcare Professionals MSD Gulf About Us Products Contact us
Email Updates
Request More Information




SINGULAIR HELPED ASTHMATIC CHILDREN FEEL BETTER
FROM DAY ONE

Many children with asthma remain symptomatic...despite reported compliance with existing asthma therapies.3,4

The Asthma in Real Life (AIR) study showed that...

 



 52%
of children still have symptoms4a,b


 68% of children used their reliever >2 times a day4a,c


 SINGULAIR significantly reduced a broad range of symptoms
5d  (p<0.005)

 SINGULAIR significantly improved daytime asthma — from
     DAY ONE
5d (p=0.017)

CHILDREN WITH ASTHMA REPORTED LIMITED DAILY ACTIVITIES
% of children reported I can NOT...


 49%
...participate in recreational activities4a,e

 45% ...do the same things as other children4a,f

 27%...socialize with friends4a,g


 50% ...sleep through the night4a,h

 

 SINGULAIR significantly improved activities — from DAY ONE1  (p=0.023)

LET KIDS BE KIDS

Airway inflammation is the underlying cause of asthma symptoms including:6,7
 Allergies
 Common Cold
 Exercise

SINGULAIR blocks the important leukotriene pathway of inflammation NOT affected by inhaled corticosteroids (ICS).7,8

Possible consequences of uncontrolled asthma may include:
 Breakthrough symptoms3
 Unscheduled clinic visits6
 Activity limitations9
 Poor quality of life9


Let Kids Be Kids

aThe AIR study assessed and compared asthma perceptions among patients and healthcare providers.  Patient surveys, distributed by UK pharmacies, were collected from 2232 respondents (536 children [8–14 years], 736 parents of children 0–14 years], and 960 adult asthma patients). Results included responses for children aged 0–14. For all children aged 0–7, a parent completed the survey. Results for children aged 8–14 were derived from a survey completed by either the child or the parent. Seventy-six percent of respondents indicated that they used a preventer therapy. Structured telephone or face-to-face interviews were conducted with 909 general practitioners and 401 practice nurses. Activity limitations were assessed by asking patients what they cannot do on a bad asthma day.3 See Study Design I for details.
bPercentage of respondents who use a controller (excluding non-compliant patients) indicating agreement with the statement that they still suffer from asthma, even if preventer is taken regularly.4
cPercentage of respondents who use a reliever (excluding non-compliant patients) indicated agreement with the statement that they still suffer from asthma, even if preventer is taken regularly.4
dA randomized, double-blind, placebo-controlled, parallel-group multicenter study of 689 asthmatic children 2 to 5 years of age. The study consisted of a 12-week active-treatment period with a 2-week single-blind placebo run-in period.5
ePercentage of all respondents (excluding non-compliant patients) indicated that they could not participate in sports and exercise activities when having a bad day with asthma.4
fPercentage of all respondents (excluding non-compliant patients) indicating agreement with the statement that there are some things asthmatics cannot do that non-asthmatic people can do.4
gPercentage of all respondents (excluding non-compliant patients) indicating agreement that they don’t socialize when having a bad day with asthma.4
hPercentage of all respondents (excluding non-compliant patients) reporting nocturnal symptoms >1 time per month.4

Back to Top
View referencesView References PrintPrint

Before prescribing, please consult the full product circular.
† Trademark of Merck & Co., Inc., Whitehouse Station, NJ, USA

Privacy Policy Terms of Use Copyright Merck & CO., Inc. (USA) Disclaimer